Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-01-21 08:30 |
Larger shareholder and board member transfer subscription rights free of charge…
|
English | 109.8 KB | ||
| 2021-01-21 08:30 |
Större aktieägare och styrelseledamot överlåter teckningsrätter vederlagsfritt …
|
Swedish | 135.1 KB | ||
| 2021-01-15 08:30 |
Alligator Bioscience tillsätter Chief Scientific Officer
|
Swedish | 101.3 KB | ||
| 2021-01-15 08:30 |
Alligator Bioscience appoints Chief Scientific Officer
|
English | 93.2 KB | ||
| 2021-01-11 08:30 |
Idag inleds teckningsperioden i Alligator Biosciences företrädesemission
|
Swedish | 120.5 KB | ||
| 2021-01-11 08:30 |
The subscription period in Alligator Bioscience’s rights issue commences today
|
English | 102.8 KB | ||
| 2020-12-30 13:45 |
Alligator Bioscience offentliggör prospekt med anledning av förestående företrä…
|
Swedish | 108.1 KB | ||
| 2020-12-30 13:45 |
Alligator Bioscience publishes prospectus in connection with forthcoming rights…
|
English | 107.7 KB | ||
| 2020-12-29 09:00 |
Alligator Bioscience utser ny Chief Medical Officer
|
Swedish | 84.4 KB | ||
| 2020-12-29 09:00 |
Alligator Bioscience recruits new Chief Medical Officer
|
English | 76.5 KB | ||
| 2020-12-28 11:00 |
Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1
|
English | 84.4 KB | ||
| 2020-12-28 11:00 |
Alligator Bioscience lämnar in CTA-ansökan för mitazalimabs fas II-studie OPTIM…
|
Swedish | 84.2 KB | ||
| 2020-12-15 08:00 |
Alligator genomför en fullt garanterad företrädesemission om cirka 86 MSEK
|
Swedish | 121.1 KB | ||
| 2020-12-15 08:00 |
Alligator carries out a fully guaranteed rights issue of approximately SEK 86m
|
English | 119.4 KB | ||
| 2020-12-10 08:31 |
Alligator Bioscience launches ALLIGATOR-FAB™ – a novel human antibody library
|
English | 77.4 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
